Lobe Sciences Ltd. LOBEF
Set alert
0.03 USD 0.00 +13.49%
As of Nov 2, 10:16 AM ET
0.0328 Day range 0.0401
0.0021 52-week range 0.0629
- YTD
- +864.71%
- 1 year
- +864.71%
- Open
- 0.0401
- Prev close
- 0.0289
- Mkt cap
- 10.11M
- Vol
- 10.30K
- Avg vol
- 77.73K
- EPS
- -0.03
- P/E
- 0.00
More statistics
- Low
- 0.0328
- High
- 0.0401
1M chart
Signals (15)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 2026 | 5 hours ago |
| MACD: Buy Signal | Nov 2, 2026 | 5 hours ago |
| MACD: Sell Signal | Oct 30, 2026 | 3 days ago |
| SMA: Bearish | Oct 29, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 28, 2026 | 5 days ago |
| SMA: Bullish | Oct 27, 2026 | 6 days ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 3 weeks ago |
News
- Lobe Sciences Appoints Tracy L. Goeken, M.D.
- Lobe Sciences Appoints Annette Grimaldi, Former Head of Life Sciences Investment Banking at BMO Capital Markets, to Board of Directors
- Lobe Sciences Announces Proposed Capital Markets Initiatives to Support Planned Growth
- Lobe Sciences to Present Low-Dose L-130 Clinical Data at 9th Neuropsychiatric Drug Development Summit
- Lobe Sciences to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto
- Lobe Sciences Ltd. Announces Closing of Upsize to Non-Brokered Private Placement
- Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement
- Lobe Sciences Expands Leadership Team with New CFO Appointment
- Lobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement
- Lobe Sciences Reports Third Quarter 2026 Financial Results
Your note
Sign in to keep a note on LOBEF — it syncs with the Stock Master app.